Iana H. Haralambieva: Role: ConceptualizationRole: Data curationRole: Formal analysisRole: InvestigationRole:
MethodologyRole: VisualizationRole: Writing – original draftRole: Writing – review
& editing
Michael J. Gibson: Role: InvestigationRole: MethodologyRole: Writing – original draftRole: Writing –
review & editing
Richard B. Kennedy: Role: ConceptualizationRole: InvestigationRole: MethodologyRole: Project administrationRole:
ResourcesRole: SupervisionRole: Writing – review & editing
Inna G. Ovsyannikova: Role: ConceptualizationRole: Project administrationRole: ResourcesRole: SupervisionRole:
Writing – review & editing
Nathaniel D. Warner: Role: Data curationRole: Formal analysisRole: SoftwareRole: VisualizationRole: Writing
– review & editing
Diane E. Grill: Role: ConceptualizationRole: Data curationRole: Formal analysisRole: MethodologyRole:
SoftwareRole: Writing – review & editing
Gregory A. Poland:
ORCID: http://orcid.org/0000-0001-5057-4457
Role: ConceptualizationRole: Funding acquisitionRole: Project administrationRole:
ResourcesRole: SupervisionRole: Writing – review & editing
John S. Tregoning: Role: Editor
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
16
November
2017
Publication date Collection: 2017
Volume: 12
Issue: 11
Electronic Location Identifier: e0188149
Affiliations
[1
]
Mayo Vaccine Research Group, Mayo Clinic and Foundation, Rochester, MN, United States
of America
[2
]
Division of Biomedical Statistics and Informatics- Department of Health Science Research,
Mayo Clinic and Foundation, Rochester, MN, United States of America
Imperial College London, UNITED KINGDOM
Author notes
Competing Interests: Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational
vaccine trials being conducted by Merck Research Laboratories. Dr. Poland offers consultative
advice on vaccine development to Merck & Co. Inc., Avianax, Dynavax, Novartis Vaccines
and Therapeutics, Adjuvance Technologies, Seqirus, and Protein Sciences. Drs. Poland
and Ovsyannikova hold three patents related to measles and vaccinia peptide research.
Dr. Kennedy has received funding from Merck Research Laboratories to study waning
immunity to measles and mumps after immunization with MMR-II. These activities have
been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted
in compliance with Mayo Clinic Conflict of Interest policies. This research has been
reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in
compliance with Mayo Clinic Conflict of Interest policies. This does not alter our
adherence to PLOS ONE policies on sharing data and materials.
Author information
Article
Publisher ID:
PONE-D-17-18827
DOI: 10.1371/journal.pone.0188149
PMC ID: 5690594
PubMed ID: 29145521
SO-VID: b3e317c1-341d-4f87-b289-55022c60ea9d
Copyright © © 2017 Haralambieva et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
Funded by: funder-id http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
Award ID: R37AI048793
Award Recipient
:
ORCID: http://orcid.org/0000-0001-5057-4457
Gregory A. Poland
Funded by: funder-id http://dx.doi.org/10.13039/100000060, National Institute of Allergy and Infectious Diseases;
Award ID: R01AI033144
Award Recipient
:
ORCID: http://orcid.org/0000-0001-5057-4457
Gregory A. Poland
This work was supported by the National Institute of Allergy And Infectious Diseases
of the National Institutes of Health under Award Numbers R37AI048793 and R01AI033144
(GAP). The content is solely the responsibility of the authors and does not necessarily
represent the official views of the National Institutes of Health. The funders had
no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Subject:
Research Article
Subject:
Biology and Life Sciences
Subject:
Physiology
Subject:
Immune Physiology
Subject:
Antibodies
Subject:
Medicine and Health Sciences
Subject:
Physiology
Subject:
Immune Physiology
Subject:
Antibodies
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Immune System Proteins
Subject:
Antibodies
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Immune System Proteins
Subject:
Antibodies
Subject:
Biology and Life Sciences
Subject:
Biochemistry
Subject:
Proteins
Subject:
Immune System Proteins
Subject:
Antibodies
Subject:
Medicine and Health Sciences
Subject:
Infectious Diseases
Subject:
Viral Diseases
Subject:
Rubella
Subject:
Biology and life sciences
Subject:
Organisms
Subject:
Viruses
Subject:
RNA viruses
Subject:
Togaviruses
Subject:
Rubella Virus
Subject:
Biology and Life Sciences
Subject:
Microbiology
Subject:
Medical Microbiology
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Togaviruses
Subject:
Rubella Virus
Subject:
Medicine and Health Sciences
Subject:
Pathology and Laboratory Medicine
Subject:
Pathogens
Subject:
Microbial Pathogens
Subject:
Viral Pathogens
Subject:
Togaviruses
Subject:
Rubella Virus
Subject:
Biology and Life Sciences
Subject:
Organisms
Subject:
Viruses
Subject:
Viral Pathogens
Subject:
Togaviruses
Subject:
Rubella Virus
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Antibody Response
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Antibody Response
Subject:
Research and Analysis Methods
Subject:
Bioassays and Physiological Analysis
Subject:
Microarrays
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Immune Response
Subject:
Medicine and health sciences
Subject:
Infectious diseases
Subject:
Infectious disease control
Subject:
Vaccines
Subject:
Viral vaccines
Subject:
MMR vaccine
Subject:
Biology and life sciences
Subject:
Microbiology
Subject:
Virology
Subject:
Viral vaccines
Subject:
MMR vaccine
Subject:
Biology and Life Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Medicine and Health Sciences
Subject:
Immunology
Subject:
Vaccination and Immunization
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health
Subject:
Preventive Medicine
Subject:
Vaccination and Immunization
